Transgene
Records under this name other than the patents Transgene holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to Transgene
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,596,533 | Mutant having uracil phosphoribosyl transferase activity Term ended Term ended Aug 14, 2020 · From the USPTO record | Term ended | Term ended Aug 14, 2020 | From the USPTO record |
| US 7,332,478 | Antitumoral composition based on immunogenic polypeptide with modified cell location Term ended Term ended Oct 26, 2018 · From the USPTO record | Term ended | Term ended Oct 26, 2018 | From the USPTO record |
| US 7,256,036 | Modified adenoviral fiber and target adenoviruses Lapsed on the fee record Ended Aug 14, 2011 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2011 | From the USPTO record |